Перейти к содержанию сайта
Anti-Inflammatory Prevents Heart Attacks
Article

Anti-Inflammatory Prevents Heart Attacks

By vindicating theory, antibody result points to new approaches to protecting the heart

Science, 2017

автоматическое преобразование текста в аудио
автоматическое преобразование текста в аудио

Editorial Rating

7

Qualities

  • Innovative
  • Scientific

Recommendation

Would you pay a premium for a drug that could reduce heart disease and lung cancer? Early evidence suggests that a juvenile arthritis drug might offer hope to people at high risk for heart attacks and strokes. The anti-inflammatory properties of canakinumab might prevent atherosclerosis that leads to heart attacks. getAbstract suggests this article to those with an interest in the inflammation theory of heart disease.

Take-Aways

  • A 10,000-patient study confirms that inflammation plays a role in heart attacks.
  • The anti-inflammatory drug canakinumab targets the pathway responsible for atherosclerosis.
  • Canakinumab now treats juvenile arthritis. The United States’ Food and Drug Administration has yet to approve it for reducing heart disease.

About the Author

Jennifer Couzin-Frankel, a Science Magazine staff writer since 2002, attended Harvard University.


Comment on this summary or Начать обсуждение

More on this topic

By the same author

Learners who read this summary also read

Related Channels